These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14559379)

  • 1. Randomised HRT trials in breast cancer survivors are justified.
    Marsden J
    Maturitas; 2003 Oct; 46(2):107-8. PubMed ID: 14559379
    [No Abstract]   [Full Text] [Related]  

  • 2. HRT and breast cancer: recent findings in the context of the evidence to date.
    Banks E; Canfell K; Reeves G
    Womens Health (Lond); 2008 Sep; 4(5):427-31. PubMed ID: 19072480
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 4. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 5. HRT, HERS, NIH, WHI: alphabet soup?
    Legato MJ
    J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and breast cancer: an overview.
    Theriault RL
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():87-90; discussion 90-1. PubMed ID: 8624349
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Should observational studies be a thing of the past?
    Weiss NS
    J Natl Cancer Inst; 2008 Aug; 100(15):1117; author reply 1117-8. PubMed ID: 18664651
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone replacement therapy and the breast cancer issue.
    Samsioe G
    Pharmacol Res; 1995 Dec; 32(6):325-6. PubMed ID: 8736480
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.
    Cobleigh MA; Berris RF; Bush T; Davidson NE; Robert NJ; Sparano JA; Tormey DC; Wood WC
    JAMA; 1994 Aug; 272(7):540-5. PubMed ID: 8046809
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone replacement therapy for breast cancer survivors: an answered question?
    Zielinski SL
    J Natl Cancer Inst; 2005 Jul; 97(13):955. PubMed ID: 15998945
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estrogens--a breast cancer risk?].
    Braendle W
    Ther Umsch; 2000 Oct; 57(10):646-50. PubMed ID: 11081377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Million Women Study: what is missing.
    Pines A
    Maturitas; 2003 Oct; 46(2):103-4. PubMed ID: 14559377
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy and breast cancer.
    Faiz O; Fentiman IS
    Int J Clin Pract; 1998 Mar; 52(2):98-101. PubMed ID: 9624790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
    Zárate A
    Gac Med Mex; 2002; 138(1):105-7. PubMed ID: 11885123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perimenopausal estrogen could prevent breast cancer - For: Estrogen replacement therapy and breast cancer.
    Manyonda I; Talaulikar V; Pirhadi R; Ward J; Banerjee D; Onwude J
    BJOG; 2021 Jul; 128(8):1384. PubMed ID: 33755295
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 19. The Million Women Study, an additional observational study with the implications and limits of an observational study.
    Braendle W
    Maturitas; 2003 Oct; 46(2):101-2. PubMed ID: 14559376
    [No Abstract]   [Full Text] [Related]  

  • 20. The sound of an International anti-HRT herald.
    Genazzani AR; Gambacciani M
    Maturitas; 2003 Oct; 46(2):105-6. PubMed ID: 14559378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.